Australian biotech industry leaders including AusBiotech, Cook Medical Australia and the Export Council of Australia have proposed an Australian Innovation & Manufacturing Incentive in their submission to the senate’s inquiry into the state of innovation in the country.
The proposed incentive would encourage companies to commercialize intellectual property in and from Australia, and works by providing a reduction in the tax payable on profits that come from the commercialization of certain intellectual property (mainly patents or licenses to patents) in Australia.
The group made the proposal collectively and is asking the government to channel it into the National Industry Investment and Competitiveness Agenda.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze